Flex Pharma Reports Year End 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P on track for muted open as Middle East tensions weigh; AI stocks boost Nasdaq
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Fulcrum Therapeutics to merge with Slate Medicines in all-stock deal
- Piper Sandler Starts SoFi Technologies (SOFI) at Overweight
Flex Pharma (FLKS) Reports Q4 Loss of $0.46/Share
March 7, 2018 7:07 AM ESTFlex Pharma (NASDAQ: FLKS) reported Q4 EPS of ($0.46), versus ($0.48) reported last year. Revenue for the quarter came in at $283 thousand, versus $291 thousand reported last year.
Financial Guidance
Based on its current operating plans and cash, cash equivalents and marketable securities position,... More
